BGI, a Microcosm of the Gene Sequencing Industry
BGI’s listing marked the most-watched IPO on the A-shares market in recent years. Though BGI’s share price has exceeded the daily trading ceiling for five consecutive trading days, the gene sequencing industry’s surge in these years has made it a “Red Ocean” with development bottlenecks throughout the industry. Therefore, many people are not optimistic about BGI’s long-term performance.
BGI is a microcosm of the gene sequencing industry. After a frenzy in 2015, a slight rational return in 2016, and a slowdown in the first half of 2017, ordinary gene sequencing companies are unable to get the attention of investors. Going forward, the key point of the industry will lie in breakthroughs in technologies or business models.